Search

You searched for "rare"

2048 results found

Practice Plus Group: Cataract - from referral to discharge

5 June 2025
Practice Plus Group is delighted to offer an accredited event for local referrers: ‘Cataract – from referral to discharge’ Discussion on local cataract acceptance criteria and the ideal patient journey from assessment to discharge. The workshop will cover a range...

UKPGS: Annual Meeting 2026

23 January 2026
UK Paediatric Glaucoma Society Annual Meeting 2026

Emergency eye care in the UK: the way forward?

1 April 2018 | | EYE - Cornea, EYE - General
In this paper the authors highlight issues pertaining to the growing number of patients presenting to the emergency eye services in the UK. Data collection involved literature review, telephone surveys and email correspondence (n=142). Ninety-one lead clinicians responded and a...

Glaukos & Glaucoma UK join forces to visit Westminster

5 August 2025 | Company Profiles, Research & Development
To mark Glaucoma Awareness Week 2025, a parliamentary drop-in session was held on Wednesday, 2nd July at Portcullis House, Westminster. Hosted by Steve Darling MP and supported by Glaucoma UK and Glaukos UK, the event brought together parliamentarians, clinicians, and...

Moorfields Education: New to Ophthalmology programme

25 March 2026 -27 March 2026
Moorfields Education: New to Ophthalmology programme

Sustainability in eyecare: Are virtual clinics the way forward in the diagnosis and monitoring of retinal disease?

2 August 2021 | | EYE - Vitreo-Retinal, EYE - General
Virtual clinics can be used successfully in screening and management of ocular conditions such as diabetic retinopathy, retinopathy of prematurity and age-related macular degeneration. Virtual clinics should be a considered as a more clinically appropriate modality of consultation, diagnosis and...

Practice tips: Directions in cataract surgery services and preventing postcataract endophthalmitis

1 August 2015 | | EYE - Cataract, EYE - Refractive
Future directions in the delivery of high quality cataract surgery services and approved intracameral prophylactic approaches to lowering the risk of postcataract infective endophthalmitis were debated by consultant ophthalmic surgeons in a recent London seminar, held at the Royal Society...

An update on inherited retinal disorders (part 1) – overview and assessment of inherited retinal disease

1 October 2016 | | EYE - Vitreo-Retinal
Part 2 of this topic can be found here Inherited Retinal Disease (IRD) is the leading cause of blindness certification in the working age population (age 16-64 years) in England and Wales and the second most common in childhood [1]....

Myasthenia gravis presenting with isolated ptosis: a poorly studied subgroup

1 February 2015 | | EYE - Vitreo-Retinal
Investigation into the cause of one isolated symptom or sign can be challenging if that particular sign may be caused by a variety of pathological processes, affecting different tissues, and presenting to different specialties. Unilateral ptosis is a case in...

Sixth nerve palsy versus decompensating distance esophoria

1 August 2019 | | EYE - Neuro-ophthalmology, EYE - General
Orthoptists see a wide range of conditions that can range from reduced binocular single vision (BSV) that may be solved with exercises, to more extreme neurogenic cases requiring further intervention. Because of this variety, it is important to be able...

Brain tumours in adults: the essentials for an ophthalmologist

1 August 2019 | | EYE - Neuro-ophthalmology, EYE - General
The author provides a review of the common intracranial tumours in adults (other than pituitaries) which may present to an ophthalmologist. Primary malignant brain tumours comprise 3% of adult cancers but with an ageing population such tumours are becoming more...

Renewed momentum in ocular gene and cell therapy, broadening application to chronic disease

5 February 2020 | | EYE - Vitreo-Retinal, EYE - General
Gene and cell therapies offer the prospect of ground-breaking new avenues for the treatment of diseases, reflected in a renewed explosion of interest and investment in retinal gene therapy. Rod McNeil reports recent clinical trial readouts across a diverse range...